Company Monitoring Page for Actavis

latest headlines for company on cafepharma

Actavis plc completes Forest Laboratories acquisition
Reuters
Tue, 07/1/14 - 11:19 am
Tags:
Actavis, Forest Labs, M&A
Teva's Nuvigil Patent Infringement Lawsuits Resolved
Yahoo/Zacks.com
Thu, 06/19/14 - 05:47 pm
Tags:
NUVIGIL, patents, Teva Pharmaceuticals, Sandoz, Apotex, Mylan Labs, Actavis, Lupin
Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry
Investors.com
Wed, 06/18/14 - 10:33 am
Tags:
Valeant Pharmaceuticals, M&A, Actavis, Allergan
Vivus hits Actavis with Qsymia patent-infringement lawsuit
Fierce Pharma
Fri, 06/13/14 - 06:46 pm
Tags:
patents, Vivus, Qsymia, Actavis, generics
Chicago Accuses Drug Companies of Pushing Opioids
Bloomberg
Tue, 06/3/14 - 10:53 am
Tags:
chicago, opioids, JNJ, Purdue Pharma, Teva Pharmaceuticals, Actavis
California counties sue over painkiller marketing
Yahoo/AP
Fri, 05/23/14 - 06:48 am
Tags:
California, painkillers, JNJ, Purdue Pharma, Actavis, Endo Health Solutions, Teva Pharmaceuticals, Cephalon, Janssen
Thoughts On The Celgene Revlimid Markman Hearing
Seeking Alpha
Fri, 05/16/14 - 10:21 am
Tags:
Celgene, Revlimid, Actavis
Lilly Loses Patent Dispute With Actavis Over Cancer Treatment
Bloomberg
Thu, 05/15/14 - 07:56 am
Tags:
patents, Actavis, Alimta, generics
Actavis says Forest CEO Brent Saunders to head company after acquisition
First Word Pharma
Wed, 05/14/14 - 11:19 am
Tags:
Brent Saunders, Forest Labs, Actavis, M&A
Vivus's diet pill faces generic threat from Actavis
Yahoo/Reuters
Fri, 05/9/14 - 10:34 am
Tags:
Vivus, generics, obesity, Qsymia, Actavis
Forest founder, CEO set for $100M-plus payoff from Actavis buyout
Fierce Pharma
Tue, 05/6/14 - 10:50 am
Tags:
Forest Labs, Actavis, M&A, Howard Solomon
Actavis sues U.S. drug regulator over generic Celebrex
Yahoo/Reuters
Tue, 04/29/14 - 08:27 am
Tags:
Actavis, generics, Pfizer, Celebrex, patents, FDA, Teva Pharmaceuticals, Mylan
Pfizer concedes Celebrex to Actavis, Teva after 2015 patent strike-down
Fierce Pharma
Thu, 04/24/14 - 11:30 am
Tags:
patents, Celebrex, Teva Pharmaceuticals, Actavis, generics
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
Tags:
M&A, Amgen, ONYX Pharmaceuticals, Bausch & Lomb, Valeant Pharmaceuticals, Elan, Perrigo, Actavis, Warner Chilcott, Bristol-Myers Squibb, AstraZeneca, Pearl Therapeutics, Agila, Mylan, Salix, Santarus, Bayer, Algeta, Shire, ViroPharma
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
Tags:
immuno-oncology, Sovaldi, Gilead Sciences, Teva Pharmaceuticals, Copaxone, GSK, Breo Ellipta, Forest Labs, Actavis, M&A, Affordable Care Act, biosimilars, PCSK9 inhibitors
Actavis shells out $100M for Thai generics maker in bid for Southeast Asia growth
Fierce Pharma
Tue, 04/1/14 - 01:25 pm
Tags:
Actavis, generics, M&A, Silom
U.S. wants at least $1 billion from drugmakers who delay generics
Yahoo/Reuters
Fri, 03/28/14 - 12:59 pm
Tags:
generics, pay-for-delay, FTC, Solvay, AbbVie, Actavis, Perrigo Company, Par Pharmaceutical, Teva, Cephalon
Grateful Actavis board adds $4M to CEO's deal-related bonus tally. Total: $49M
Fierce Pharma
Wed, 03/12/14 - 07:07 pm
Tags:
executive pay, Actavis, Warner Chilcott, M&A
Drugmakers Actavis, Biogen, Valeant Hold Near Highs
Investors.com
Tue, 03/4/14 - 10:17 pm
Tags:
Valeant Pharmaceuticals, Actavis, Biogen Idec
Will Pharma's Future Be Based On The Carl Icahn Business Model?
Forbes
Tue, 03/4/14 - 08:37 am
Tags:
Carl Icahn, Actavis, Forest Labs, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.